Skip to main content

Published locations for ER+/HER2− BC: ET+bevacizumab switch is an efficacious and safer alternative to paclitaxel

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ER+/HER2− BC: ET+bevacizumab switch is an efficacious and safer alternative to paclitaxel

User login

  • Reset your password
  • /content/er/her2-bc-etbevacizumab-switch-efficacious-and-safer-alternative-paclitaxel
  • /hematology-oncology/article/254747/breast-cancer/er/her2-bc-etbevacizumab-switch-efficacious-and
  • /breast-cancer-icymi/article/254747/breast-cancer/er/her2-bc-etbevacizumab-switch-efficacious-and